Image-guided Brachytherapy for Vaginal Cancer (EMBRAVE)

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

November 28, 2022

Primary Completion Date

November 30, 2033

Study Completion Date

November 30, 2033

Conditions
Vaginal Neoplasms
Interventions
OTHER

Observational study (Non-interventional study)

This is an observational study.

Trial Locations (1)

3015 CD

RECRUITING

Erasmus MC, Rotterdam

Sponsors
All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

collaborator

Amsterdam University Medical Center

OTHER

collaborator

Gustave Roussy, Cancer Campus, Grand Paris

OTHER

collaborator

Pitié-Salpêtrière Hospital

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

Medical University of Vienna

OTHER

lead

Erasmus Medical Center

OTHER

NCT06514235 - Image-guided Brachytherapy for Vaginal Cancer (EMBRAVE) | Biotech Hunter | Biotech Hunter